16 research outputs found

    Cost analysis of psoriasis treatment modalities in Malaysian public hospitals

    Get PDF
    Psoriasis imposes a great economic burden as a result of higher expenditures for different interventions, diagnostic procedures, pharmaceuticals and loss of productivity. Less is known about the economic impact of psoriasis treatment in Asean region. The aim of this research was to calculate the costs associated with four psoriasis treatment modalities. A prospective cohort study was conducted in five hospitals involving 91 moderate to severe psoriasis patients. Costs were calculated from the societal perspective using the principle of Step Down and Activity Based Costing (ABC) within a six (6) months follow-up duration. The components of the costs borne by the provider were inpatient cost, cost of medication, laboratory investigation and radiology. Patient’s cost included out of pocket expenses, travelling cost and loss of productivity. Cost per patient per day was RM1,105.24 (inpatient) (US315.94)andRM298.02(outpatient)(US315.94) and RM298.02 (outpatient) (US85.19). Medication accounted for almost 90% (RM457,014.00) (US130638.45)ofthetotalprovidercost.Meanwhile,lossofproductivityrepresented84130 638.45) of the total provider cost. Meanwhile, loss of productivity represented 84% (RM167,439.00) (US47,862.80) of the total patient’s cost. Biologic treatment exhibited the highest cost which was RM342,377.00 (US97,869.21),followedbysystemictreatment(RM105,607.00)(US97,869.21), followed by systemic treatment (RM105,607.00) (US30,187.99), topical treatment (RM38,280.00) (US10,942.42)andtopicalphototherapytreatment(RM21,824.00)(US10,942.42) and topical phototherapy treatment (RM21,824.00) (US6,238.44). Understanding the relationship between direct and indirect costs from both perspectives is important to accurately identify and evaluate effective treatment for psoriasis

    Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Pneumococcal disease is the leading cause of vaccine-preventable death in children younger than 5 years of age worldwide. The World Health Organization recommends pneumococcal conjugate vaccine as a priority for inclusion into national childhood immunization programmes. Pneumococcal vaccine has yet to be included as part of the national vaccination programme in Malaysia although it has been available in the country since 2005. This study sought to estimate the disease burden of pneumococcal disease in Malaysia and to assess the cost effectiveness of routine infant vaccination with PCV7.</p> <p>Methods</p> <p>A decision model was adapted taking into consideration prevalence, disease burden, treatment costs and outcomes for pneumococcal disease severe enough to result in a hospital admission. Disease burden were estimated from the medical records of 6 hospitals. Where local data was unavailable, model inputs were obtained from international and regional studies and from focus group discussions. The model incorporated the effects of herd protection on the unvaccinated adult population.</p> <p>Results</p> <p>At current vaccine prices, PCV7 vaccination of 90% of a hypothetical 550,000 birth cohort would incur costs of RM 439.6 million (US128million).Overa10yeartimehorizon,vaccinationwouldreduceepisodesofpneumococcalhospitalisationby9,585casesto73,845hospitalisationswithcostsavingsofRM37.5million(US128 million). Over a 10 year time horizon, vaccination would reduce episodes of pneumococcal hospitalisation by 9,585 cases to 73,845 hospitalisations with cost savings of RM 37.5 million (US10.9 million) to the health system with 11,422.5 life years saved at a cost effectiveness ratio of RM 35,196 (US10,261)perlifeyeargained.</p><p>Conclusions</p><p>PCV7vaccinationofinfantsisexpectedtobecosteffectiveforMalaysiawithanincrementalcostperlifeyeargainedofRM35,196(US10,261) per life year gained.</p> <p>Conclusions</p> <p>PCV7 vaccination of infants is expected to be cost-effective for Malaysia with an incremental cost per life year gained of RM 35,196 (US10,261). This is well below the WHO's threshold for cost effectiveness of public health interventions in Malaysia of RM 71,761 (US$20,922).</p

    Clinical pathway as a strategy in improving healthcare quality and cost containment

    Get PDF
    The increasing health care cost and public awareness on the delivery of high quality services has forced healthcare service providers to look into the healthcare delivery system. Clinical Pathway (CP) has been introduced in many hospitals and has been accepted as a beneficial tool in assisting healthcare organizations worldwide. Further, the CP also provides consistently high quality and coordinates services with minimum resources. It is proven to be a beneficial tool in other countries. CP is recently being introduced into the Malaysian healthcare system. The aim of this article was to high-light the benefits of CP in improving healthcare quality and controlling the medical cost. The relevant articles have been reviewed. The majority of literature reviewed con-cluded that there were positive effects in implementing CP. The CP was found to be significant in reducing length of stay and medical cost. The introduction of evidence based medicine, clinical outcomes, clinical audit, multidisciplinary communication, teamwork and care planning were also improved by CP. The challenges for healthcare providers and healthcare managers are to participate and be fully committed in path-way development and implementation in order to improve healthcare quality and cost contro

    Developing the cost for uncomplicated scute st elevated myocardial infarction (Stemi primary percutaneous coronary intervention) using step down and activity based costing at UKMMC

    Get PDF
    Background : Cardiovascular disease is the number one cause of death globally and is projected to remain the leading cause of death. If the trend is allowed to continue, by 2015 an estimated 20 million people will die from cardiovascular disease (mainly because of myocardial infarction and strokes). The number of cardiovascular disease cases in Malaysia has increased to 14% in five years from 96,000 cases in 1995 to 110,000 cases in 2000. Methods : The cost to treat patients admitted to Universiti Kebangsaan Malaysia Medical Center (UKMMC) Malaysia, diagnosed with Acute Uncomplicated ST Elevated Myocardial Infarction (STEMI) was calculated by using two different methodologies, namely step down costing methodology and activity based costing using clinical pathway. Result : Cost for each stay per day at the cardiology ward using the step down methodology is RM596.42. The treatment cost is estimated from RM1, 789.26 to RM 4,771.36. The average cost per episode for STEMI care with the average length of stay for 5.6 days is RM3, 340(SD ±596.42. The cost of coronary PCI procedure in step costing is RM 13,950.00. Hence, the total cost incurs for STEMI with PCI is RM 17,290.00(SD ±596.42) by using step down method. (an average cost per episode is RM3,340, plus the cost of coronary procedure of RM 13,950.00 . However by using the ABC the cost of STEMI (PCI) with an average length of stay for 5.6 days is RM 20,431.39. The study showed the ABC method was higher by 15.3% than the step down costing. Conclusion : The cost in managing STEMI (PCI) with the average length of stay of 5.6 days was calculated by using two different methodologies, namely step down costing methodology and activity based costing. Cost of treatment calculated by using activity based costing are higher because all resources used are incorporated in detail. The ABC method was higher by 15.3% than the step down costing. The difference is within 80-20 rules and the biggest percentage of cost in both methods is procedure or PCI cost

    MYOCARDIAL INFARCTION (STEMI PRIMARY PERCUTANEOUS CORONARY INTERVENTION) USING STEP DOWN AND ACTIVITY BASED COSTING AT UKMMC

    No full text
    ABSTRACT Background: Cardiovascular disease is the number one cause of death globally and is projected to remain the leading cause of death. If the trend is allowed to continue, by 2015 an estimated 20 million people will die from cardiovascular disease (mainly because of myocardial infarction and strokes). The number of cardiovascular disease cases in Malaysia has increased to 14% in five years from 96,000 cases in 1995 to 110,000 cases in 2000. Methods: The cost to treat patients admitted to Universiti Kebangsaan Malaysia Medical Center (UKMMC) Malaysia, diagnosed with Acute Uncomplicated ST Elevated Myocardial Infarction (STEMI) was calculated by using two different methodologies, namely step down costing methodology and activity based costing using clinical pathway. Results: Cost for each stay per day at the cardiology ward using the step down methodology is RM596.42. The treatment cost is estimated from RM1, 789.26 to RM 4,771.36. The average cost per episode for STEMI care with the average length of stay for 5.6 days is RM3, 340(SD ±596.42. The cost of coronary PCI procedure in step costing is RM 13,950.00. Hence, the total cost incurs for STEMI with PCI is RM 17,290.00(SD ±596.42) by using step down method. (an average cost per episode is RM3,340, plus the cost of coronary procedure of RM 13,950.00 . However by using the ABC the cost of STEMI (PCI) with an average length of stay for 5.6 days is RM 20,431.39. The study showed the ABC method was higher by 15.3% than the step down costing. Conclusion: The cost in managing STEMI (PCI) with the average length of stay of 5.6 days was calculated by using two different methodologies, namely step down costing methodology and activity based costing. Cost of treatment calculated by using activity based costing are higher because all resources used are incorporated in detail. The ABC method was higher by 15.3% than the step down costing. The difference is within 80-20 rules and the biggest percentage of cost in both methods is procedure or PCI cost

    Understanding probabiity concepts and learning styles among students of the Malay culture: a Rasch analysis

    No full text
    Research relating to the understanding of probability concepts among students have been investigated from various different perspectives and this study is no exception. The purpose of is to examine students’ perceived understanding and competency in probability concepts while focusing on the learning styles among students of the Malay culture. A convenient sample of 81 undergraduate students from the mathematical and computer sciences programmes at a local public university in Malaysia were subjected to a survey investigation. An attempt in using Rasch analysis to explore students’ perceived understanding and competency revealed that students perceived a good understanding of probability concepts after they have gone through lessons on probability concepts, as measured by the relevant constructs. The study also revealed that having a good understanding of the concepts does not necessarily mean that students possessed a high ability to perform well in the test. In its connection with the learning styles, more than half of the students interviewed consider themselves as assimilators, i.e., preference for reviewing, reflecting and learning from experience followed by converger, i.e., trying out what have been learned
    corecore